InvenireX Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$2.68M
- Investors
-
6
InvenireX General Information
Description
Developer of a molecular diagnostics platform designed to democratize and accelerate life science research. The company's platform possesses limits of detection, several orders of magnitude lower than current, commonly used diagnostic methods of detection, enabling biotech researchers to live detection of nucleic acids, ribonucleic acid, and proteins through video-feed with single-molecule precision using artificial intelligence.
Contact Information
Website
www.invenirex.co.ukCorporate Office
- D1 Milburn House
- Dean Street
- Newcastle Upon Tyne NE1 1LF
- England, United Kingdom
Corporate Office
- D1 Milburn House
- Dean Street
- Newcastle Upon Tyne NE1 1LF
- England, United Kingdom
InvenireX Timeline
InvenireX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC | 15-Aug-2025 | $2.68M | Completed | Generating Revenue | ||
| 3. Early Stage VC | 18-Mar-2024 | Completed | Product In Beta Test | |||
| 2. Early Stage VC | 08-Sep-2023 | $506K | $628K | Completed | Product In Beta Test | |
| 1. Accelerator/Incubator | 01-Jan-2023 | $122K | $122K | Completed | Startup |
InvenireX Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| E Ordinary | ||||||||
| C Oridnary | ||||||||
| E Ordinary | ||||||||
| A5 Ordinary | ||||||||
| A1 Ordinary | ||||||||
| C Oridnary | ||||||||
| A4 Ordinary | ||||||||
| A3 Ordinary | 13,817 | $0.000013 | $16.8 | $16.8 | 1x | $16.8 | 7.11% | |
| A1 Ordinary | 13,802 | $0.000013 | $16.8 | $16.8 | 1x | $16.8 | 7.1% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
InvenireX Signals
InvenireX Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cambridge Technology Capital Fund | Mezzanine | Minority | ||
| Innovate UK | Government | |||
| Angel (individual) | Minority | |||
| DSW Ventures | Venture Capital | Minority | ||
| XTX Ventures | Corporate Venture Capital | Minority |
InvenireX FAQs
-
When was InvenireX founded?
InvenireX was founded in 2021.
-
Where is InvenireX headquartered?
InvenireX is headquartered in Newcastle Upon Tyne, United Kingdom.
-
What is the size of InvenireX?
InvenireX has 11 total employees.
-
What industry is InvenireX in?
InvenireX’s primary industry is Discovery Tools (Healthcare).
-
Is InvenireX a private or public company?
InvenireX is a Private company.
-
What is the current valuation of InvenireX?
The current valuation of InvenireX is .
-
What is InvenireX’s current revenue?
The current revenue for InvenireX is .
-
How much funding has InvenireX raised over time?
InvenireX has raised $3.93M.
-
Who are InvenireX’s investors?
Cambridge Technology Capital Fund, Innovate UK, , DSW Ventures, and XTX Ventures are 5 of 6 investors who have invested in InvenireX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process